Related Experiment Video
Updated: Aug 16, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Persistence with treatment in newly treated middle-aged patients with essential hypertension
Sylvie Perreault1, Diane Lamarre, Lucie Blais
1Faculty of Pharmacy, University of Montreal, Québec, Canada. sylvie.perreault@umontreal.ca
Insights
Patient persistence with antihypertensive medication declines significantly within three years, with diuretics showing the lowest adherence rates. Early intervention is crucial for improving long-term cardiovascular disease management.
Area of Science:
- Pharmacology
- Cardiology
- Public Health
Background:
- Antihypertensive agents reduce cardiovascular disease (CVD) morbidity/mortality.
- Hypertension remains uncontrolled in many diagnosed patients, potentially due to poor treatment persistence.
- Understanding persistence is key to improving hypertension management.
Purpose of the Study:
- To evaluate persistence with antihypertensive medications.
- To identify determinants of persistence among newly treated patients.
Main Methods:
- A cohort of 21,011 newly treated essential hypertension patients (50-64 years) was analyzed.
- Prescription data from 1998-2000 from Quebec administrative database used.
- Kaplan-Meier and Cox regression models assessed persistence rates and discontinuation factors over 3 years.
Main Results:
- Persistence dropped from 75% at 6 months to 55% over 3 years.
- Non-diuretic antihypertensives or combination therapy improved persistence (HR 0.71).
- Diabetes (HR 0.86) and dyslipidemia (HR 0.71) were associated with increased persistence.
Conclusions:
- Persistence barriers emerge early, with adherence declining over time.
- Diuretic therapy demonstrated the lowest patient persistence rates.
- Strategies to enhance early adherence are vital for effective hypertension control.
Background:
Antihypertensive agents have been found to decrease morbidity and/or mortality associated with cardiovascular disease (CVD). Surveys have shown that hypertension has been diagnosed in many patients but remains uncontrolled. One factor may be the lack of persistence to treatment.
Objective:
To evaluate persistence with antihypertensives and its determinants among newly treated patients.
Methods:
A cohort of 21,011 patients with essential hypertension was reconstructed from prescription records in the Régie de l'assurance maladie du Québec administrative database. We included subjects between 50 and 64 years of age newly treated for hypertension with diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, calcium-channel blockers, or angiotensin II receptor blockers prescribed individually or in combination. Cohort entry was from January 1, 1998, to December 31, 2000. Subjects were considered newly treated if they had not taken any antihypertensive agents in the year prior to the index date, which was defined as the date of the first prescription. Patients were followed until June 30, 2001; death; end of coverage; or occurrence of CVD. Main outcome measure was the persistence rate. The cumulative persistence rate was determined by Kaplan-Meier analysis. The rate ratio of discontinuing antihypertensive therapy was estimated using the Cox regression model.
Results:
The mean age of patients was 58 years. Persistence with antihypertensive therapy fell to 75% in the first 6 months after treatment and continued to decline over the next 3 years to 55%. During a one-year period of follow-up, with diuretics used as the reference class and controlling for several variables, patients prescribed other antihypertensive classes or combined therapy (HR 0.71; 95% CI 0.67 to 0.75) were found to have a better rate of persistence. Having diabetes (HR 0.86; 95% CI 0.79 to 0.94) and dyslipidemia (HR 0.71; 95% CI 0.66 to 0.76) increased the rate of persistence. Similar values were observed during the 3-year period of follow-up.
Conclusions:
Barriers to persistence occur early in the course of therapy, and adherence continues to decline over a period of 3 years. Patients were least persistent to diuretic therapy.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension I: Introduction
Hypertension II: Pathophysiology
Atherosclerosis III: Management